IMIrina Elena Muntean

Irina Elena Muntean

*This is an algorithmically generated author record based on publicly available information.

Irina Elena Muntean has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Claudiu Mărginean

    Department of Obstetrics and Gynecology, University of Medicine Pharmacy Science and Technology George Emil Palade of Târgu Mures, 540142 Târgu Mures, Romania

    3 shared publications
  • Mihai Muntean

    Department of Obstetrics and Gynecology, University of Medicine Pharmacy Science and Technology George Emil Palade of Târgu Mures, 540142 Târgu Mures, Romania

    3 shared publications
  • Victoria Nyulas

    Department of Medical Informatics and Biostatistics, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Gheorghe Marinescu Street No. 38, 540136 Targu Mures, Romania

    3 shared publications
  • Vladut Săsăran

    Department of Obstetrics and Gynecology 2, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540142 Targu Mures, Romania

    3 shared publications
  • Alexandru Stefan Zalana

    Faculty of Dentistry, Titu Maiorescu University, Gheorghe Petrașcu Street, 031593 Bucharest, Romania

    2 shared publications
  • Eugen Bud

    Department of Orthodontics, Faculty of Dental Medicine, George Emil Palade University Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gh. Marinescu Str., 540139 Târgu Mureș, Romania

    2 shared publications

Latest Publications

  • Open Access

    Exploratory Analysis of Dental Age Differences in Children with Type 1 Diabetes Using the Demirjian Method

    by Maria Simona DămășAru, Eugen Bud, Sorana Maria Bucur, Mariana Păcurar, Manuela Chibelean, Silvia-Izabella Pop, Alexandru Ștefan Zalana, Irina Elena Muntean, Lucian Cristian Petcu, Mariana Cornelia Tilinca

    Background: Chronological age does not always accurately reflect biological maturation in children, particularly in the presence of systemic conditions. Dental age is widely used as a biological maturity indicator; however, the impact of Type 1 diabetes mellitus on dental development remains unclear and inconsistently reported. Objective: This paper aims to explore differences between dental age (DA) and chronological age (CA) in children with Type 1 diabetes compared to healthy controls, and to assess the association between glycemic control (HbA1c) and dental maturation. Materials and Methods: This observational comparative study included 90 children aged 8–15 years: 45 with Type 1 diabetes and 45 age- and sex-matched healthy controls. Dental age was estimated using the Demirjian method and compared with chronological age. Group comparisons were performed using independent t-tests, while paired t-tests assessed within-group differences. Linear regression analysis evaluated the association between HbA1c and dental age. Effect sizes and 95% confidence intervals were reported. Results: In the diabetes group, dental age was significantly higher than chronological age (mean difference = 1.56 years, p < 0.001), indicating advanced dental maturation. No significant difference between dental and chronological age was observed in the control group. Dental age was also significantly higher in the diabetes group compared to controls (mean difference = 1.61 years, p < 0.001; Cohen’s d = 0.93). HbA1c levels were positively associated with dental age (R2 = 0.409, p < 0.01), suggesting that metabolic control may contribute to variability in dental maturation. Conclusions: Children with Type 1 diabetes appear to exhibit advanced dental maturation compared to healthy peers. Glycemic control may be associated with this variation, although the findings should be interpreted within the exploratory framework of the study. Dental age assessment should be used cautiously and in conjunction with other maturity indicators, particularly in children with systemic conditions.

  • Open Access

    Dental Age Advancement Among Children with Juvenile Diabetes Mellitus Using the Demirjian Method

    by Maria Simona Dămășaru, Sorana Maria Bucur, Eugen Bud, Mariana Păcurar, Alexandru Zalana, Irina Elena Muntean, Elena Dămășaru, Mariana Cornelia Tilinca

    Background: Chronological age does not always accurately reflect biological matura-tion in children, particularly in the presence of systemic diseases. Dental age assess-ment is widely used as a biological maturity indicator; however, the effect of juvenile diabetes mellitus on dental maturation remains insufficiently clarified, with incon-sistent findings reported across populations. Objective: This study aimed to compare dental age estimated using the Demirjian method with chronological age in children with juvenile diabetes and in age- and sex-matched healthy controls. Materials and Methods: This observational comparative study included panoramic radiographs from 30 children aged 8–15 years: 15 patients diagnosed with juvenile diabetes mellitus and 15 systemically healthy controls, all presenting Angle Class I malocclusion. Dental age was assessed using the Demirjian method and compared with chronological age. Ap-propriate parametric or non-parametric statistical tests were applied based on data distribution. Results: Children with juvenile diabetes exhibited a statistically signifi-cant advancement in dental age relative to chronological age, with a mean DA–CA difference of 1.36 years (p = 0.0066). No statistically significant differences between dental and chronological age were observed in the control group. Sexual dimorphism was evident from crown completion stages onward, with females demonstrating earli-er dental maturation. Conclusions: Juvenile diabetes mellitus is associated with accel-erated dental maturation. These findings have clinical implications for orthodontic treatment timing and growth assessment and indicate a potential risk of age overesti-mation in forensic contexts. Dental age should therefore be interpreted alongside skel-etal and chronological indicators, particularly in pediatric patients with systemic metabolic conditions.

  • Open Access

    Adiponectin C1Q and Collagen Domain Containing rs266729, Cyclin-Dependent Kinase Inhibitor 2A and 2B rs10811661, and Signal Sequence Receptor Subunit 1 rs9505118 Polymorphisms and Their Association with Gestational Diabetes Mellitus: A Case-Control Study in a Romanian Population

    by Mihai Muntean, Claudiu Mărginean, Elena Silvia Bernad, Claudia Bănescu, Victoria Nyulas, Irina Elena Muntean, Vladut Săsăran

    Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) are public health concerns worldwide. These two diseases share the same pathophysiological and genetic similarities. This study aimed to investigate the T2DM known single nucleotide polymorphisms (SNPs) of the adiponectin C1Q and collagen domain containing (ADIPOQ), cyclin-dependent kinase inhibitor 2A and 2B (CDKN2A/2B), and signal sequence receptor subunit 1 (SSR1) genes in a cohort of Romanian GDM pregnant women and perinatal outcomes. DNA was isolated from the peripheral blood of 213 pregnant women with (n = 71) or without (n = 142) GDM. Afterward, ADIPOQ (rs266729), CDKN2A/2B (rs10811661), and SSR1 (rs9505118) gene polymorphisms were genotyped using TaqMan Real-Time PCR analysis. Women with GDM had a higher pre-pregnancy body mass index (BMI) (p < 0.0001), higher BMI (p < 0.0001), higher insulin resistance homeostatic model assessment (IR-HOMA) (p = 0.0002), higher insulin levels (p = 0.003), and lower adiponectin levels (p = 0.004) at birth compared to pregnant women with normoglycemia. GDM pregnant women had gestational hypertension (GH) more frequently during pregnancy (p < 0.0001), perineal lacerations more frequently during vaginal birth (p = 0.03), and more macrosomic newborns (p < 0.0001) than pregnant women from the control group. We did not find an association under any model (allelic, genotypic, dominant, or recessive) of ADIPOQ rs266729, CDKN2A/2B rs10811661, and SSR1 rs9505118 polymorphisms and GDM. In correlation analysis, we found a weak positive correlation (r = 0.24) between the dominant model GG + CG vs. CC of rs266729 and labor induction failure. In the dominant model TT vs. CC + CT of rs10811661, we found a weak negative correlation between this model and perineal lacerations. Our results suggest that the ADIPOQ rs266729, the CDKN2A/2B rs10811661, and the SSR1 rs9505118 gene polymorphisms are not associated with GDM in a cohort of Romanian pregnant women.


  • Open Access

    Subclinical Hypothyroidism and Gestational Hypertensive Disorders in a Cohort of Romanian Pregnant Women with Gestational Diabetes Mellitus: A Pilot Study

    by Muntean Mihai, Săsăran Vladut, Pop Gheorghe Lucian, Muntean Elena Irina, Nyulas Victoria, Mărginean Claudiu

    Objective: This study aimed to explore whether subclinical hypothyroidism (SCH) treated with levothyroxine in pregnancy complicated by gestational diabetes mellitus (GDM) is associated with an increased risk of gestational hypertensive disorders (GHDs) (gestational hypertension and preeclampsia). Methods: 96 pregnant women with GDM were enrolled in this study and grouped as per the European Thyroid Association criteria into the SCH (n = 21) and euthyroid groups (n = 75). All subjects were tested for anthropometric parameters, maternal glucose homeostasis parameters, lipid levels, thyroid function tests, and blood pressure. All GDM pregnant women received nutritional and insulin therapy where needed, and the SCH group received levothyroxine treatment. Then, the maternal and newborn outcomes were compared. Data were analyzed using Student’s t-test, Mann–Whitney U, and Chi-square tests wherever applicable. p values of 0.05). Patients with GDM and SCH treated with levothyroxine had more premature delivery than the euthyroid group (p = 0.03). Conclusions: Subclinical hypothyroidism treated with levothyroxine in women with GDM does not increase the risk of gestational hypertensive disorders, but is associated with increased risk for prematurity.


  • Open Access

    Correlation between Overweight, Obesity, Gestational Diabetes Mellitus, Adipokines (Adipolin and Adiponectin), and Adverse Pregnancy Outcomes: A Pilot Study

    by Muntean Mihai, Săsăran Vladut, Luca Sonia-Teodora, Suciu Laura Mihaela, Nyulas Victoria, Muntean Irina Elena, Mărginean Claudiu

    Background: The prevalence of overweight (OW), obesity (OB), and gestational diabetes mellitus (GDM) has been increasing worldwide in recent years. Adipolin is a new adipokine with reduced circulating levels in obesity and type 2 diabetes mellitus (T2DM). Objectives: Our prospective case-control study aimed to evaluate the maternal serum levels of adipolin and adiponectin, metabolic parameters, and anthropometric characteristics at the time of oral glucose tolerance test (OGTT) in pregnant women with a pre-pregnancy body mass index (BMI) ≥ 25 Kg/m2 and correlate them with newborn adipolin, adiponectin levels, and anthropometric characteristics of the newborns, and secondly to evaluate pregnancy outcomes. Material and Methods: After the OGTT results, we had 44 OW/OB pregnant women with GDM, 30 OW/OB pregnant women without GDM, and 92 lean healthy (LH) pregnant women. Data were analyzed by ANOVA and correlation tests, with a p-value < 0.05 considered significant. Results: We found no differences between adipolin values of the OW/OB pregnant women with GDM and the LH group (p > 0.99), OW/OB without GDM and the LH group (p = 0.56), and between OW/OB groups (p = 0.57). OW/OB pregnant women with GDM had a higher rate of gestational hypertension compared with the LH group (p < 0.0001). Newborns from OW/OB pregnant women with GDM were more frequently diagnosed with jaundice (p = 0.02), and they required more frequent admission to the neonatal intensive care unit (NICU) for treatment of respiratory distress (p = 0.01) compared with newborns from LH mothers. Conclusions: Our study revealed that the serum levels of adipolin in the second trimester among the group of OW/OB pregnant women with GDM, matched for age and BMI with OW/OB pregnant women without GDM, were not significantly different. This suggests that adipolin may not play an essential role in the occurrence of GDM in these patients. Despite good glycemic control during pregnancy, OW/OB pregnant women with GDM and their newborns tend to have more complications (gestational hypertension, jaundice, NICU admission) than LH pregnant women and their newborns, highlighting the importance of weight control before pregnancy.


  • Open Access

    The Role of Formative Intervention in Diabetes in Primary and Secondary School Teachers

    by Maria-Melania Lica, Annamaria Porkolab, Irina Muntean, Adriana Mihai

    The children with diabetes mellitus have often difficulties regarding school adaptation and integration, generated largely by the special conditions of the disease. On the other hand, how the child succeds in this adaptation, interferes with the management of chronic disease and the quality of his life. An important role for the child with diabetes in school is played by the head teachers.The informations about this disease and the attitude towards the children affected by this disease are important variables in this direction. The objective of our study is improving the teachers knowledge and attitude toward diabetes in children by providing quality information and practical intervention techniques. 86 head teachers from elementary and secondary schools were interviewed regarding their knowledge about diabetes in children, and participated to a formative course about this disease. After their participation in a theoretical and practical training course, their knowledge and their attitude have been improved considerably and the follow-up evaluation (after 3 months) indicated a stability of informations and practical techniques for granting first aid, over time. The conclusion is that formative intervention of teachers is an important step in helping children with diabetes to better school adaptation and, also in improving the quality of their life.